Literature DB >> 11895368

Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice.

Kiyonori Miura1, Tatsuya Kishino, En Li, Hayley Webber, Pieter Dikkes, Gregory L Holmes, Joseph Wagstaff.   

Abstract

Angelman syndrome (AS), characterized by motor dysfunction, mental retardation, and seizures, is caused by several genetic etiologies involving chromosome 15q11-q13, including mutations of the UBE3A gene. UBE3A encodes UBE3A/E6-AP, a ubiquitin-protein ligase, and shows brain-specific imprinting, with brain expression predominantly from the maternal allele. Lack of a functional maternal allele of UBE3A causes AS. In order to understand the causal relationship between maternal UBE3A mutations and AS, we have constructed a mouse model with targeted inactivation of Ube3a. The inactive allele contains a lacZ reporter gene for analysis of brain-specific imprinting. Maternal, but not paternal, transmission of the targeted allele leads to beta-galactosidase activity in hippocampal and cerebellar neurons. Maternal inheritance of the Ube3a mutant allele also causes impaired performance in tests of motor function and spatial learning, as well as abnormal hippocampal EEG recordings. As predicted from the dependence of UBE3A-mediated ubiquitination of p53 on HPV E6 protein, our maternal-deficient mice show normal brain p53 levels. (c)2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895368     DOI: 10.1006/nbdi.2001.0463

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  103 in total

1.  Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.

Authors:  Richard M Gustin; Terry Jo Bichell; Michael Bubser; Jennifer Daily; Irina Filonova; Davit Mrelashvili; Ariel Y Deutch; Roger J Colbran; Edwin J Weeber; Kevin F Haas
Journal:  Neurobiol Dis       Date:  2010-04-25       Impact factor: 5.996

2.  A neurodevelopmental survey of Angelman syndrome with genotype-phenotype correlations.

Authors:  Jennifer K Gentile; Wen-Hann Tan; Lucia T Horowitz; Carlos A Bacino; Steven A Skinner; Rene Barbieri-Welge; Astrid Bauer-Carlin; Arthur L Beaudet; Terry Jo Bichell; Hye-Seung Lee; Trilochan Sahoo; Susan E Waisbren; Lynne M Bird; Sarika U Peters
Journal:  J Dev Behav Pediatr       Date:  2010-09       Impact factor: 2.225

Review 3.  Pharmacological therapies for Angelman syndrome.

Authors:  Wen-Hann Tan; Lynne M Bird
Journal:  Wien Med Wochenschr       Date:  2016-01-12

Review 4.  The role of GNAS and other imprinted genes in the development of obesity.

Authors:  L S Weinstein; T Xie; A Qasem; J Wang; M Chen
Journal:  Int J Obes (Lond)       Date:  2009-10-20       Impact factor: 5.095

Review 5.  Stem cells and modeling of autism spectrum disorders.

Authors:  Beatriz C G Freitas; Cleber A Trujillo; Cassiano Carromeu; Marianna Yusupova; Roberto H Herai; Alysson R Muotri
Journal:  Exp Neurol       Date:  2012-10-02       Impact factor: 5.330

6.  E6AP in the brain: one protein, dual function, multiple diseases.

Authors:  Jimmy El Hokayem; Zafar Nawaz
Journal:  Mol Neurobiol       Date:  2013-10-05       Impact factor: 5.590

7.  Ube3a reinstatement mitigates epileptogenesis in Angelman syndrome model mice.

Authors:  Bin Gu; Kelly E Carstens; Matthew C Judson; Katherine A Dalton; Marie Rougié; Ellen P Clark; Serena M Dudek; Benjamin D Philpot
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

8.  Sex-Dependent Sensory Phenotypes and Related Transcriptomic Expression Profiles Are Differentially Affected by Angelman Syndrome.

Authors:  Lee Koyavski; Julia Panov; Lilach Simchi; Prudhvi Raj Rayi; Lital Sharvit; Yonatan Feuermann; Hanoch Kaphzan
Journal:  Mol Neurobiol       Date:  2019-01-31       Impact factor: 5.590

Review 9.  Epilepsy in Prader-Willi syndrome: clinical, diagnostic and treatment aspects.

Authors:  Alberto Verrotti; Claudia Soldani; Daniela Laino; Renato d'Alonzo; Salvatore Grosso
Journal:  World J Pediatr       Date:  2014-05-07       Impact factor: 2.764

Review 10.  The molecular basis of cognitive deficits in pervasive developmental disorders.

Authors:  Aditi Bhattacharya; Eric Klann
Journal:  Learn Mem       Date:  2012-08-16       Impact factor: 2.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.